Search Results

Return to List
Results 1–20 of 21
Title Date
1.

Carrier Screening for Fragile X Syndrome

Number 469

(Reaffirmed 2014, Replaces No. 338, June 2006)

October 2010

PDF Format
2.

Cell-free DNA Screening for Fetal Aneuploidy

Number 640

(This Committee Opinion Replaces Committee Opinion Number 545, Published Electronically Ahead of Print on June 26, 2015)

September 2015

PDF Format
3.

Direct-to-Consumer Marketing of Genetic Testing

Number 409

Reaffirmed 2014

June 2008

PDF Format
4.

Ethical Issues in Genetic Testing

Number 410

(Reaffirmed 2014)

June 2008

PDF Format
5.

Family History as a Risk Assessment Tool

Number 478

(Reaffirmed 2015)

March 2011

PDF Format
6.

Hereditary Cancer Syndromes and Risk Assessment

Number 634

June 2015

PDF Format
7.

Management of Women With Phenylketonuria

Number 636

(Replaces Committee Opinion Number 449, December 2009)

June 2015

PDF Format
8.

Maternal–Fetal Surgery for Myelomeningocele

Number 550

January 2013

PDF Format
9.

Newborn Screening and the Role of the Obstetrician-Gynecologist

Number 616

(Replaces Committee Opinion Number 481, March 2011)

January 2015

PDF Format
10.

Noninvasive Prenatal Testing for Fetal Aneuploidy

Number 545

December 2012

PDF Format
11.

Perinatal Risks Associated With Assisted Reproductive Technology

Number 324

(Reaffirmed 2007)

November 2005

PDF Format
12.

Personalized Genomic Testing for Disease Risk

Number 527

(Reaffirmed 2014)

June 2012

PDF Format
13.

Pharmacogenetics

Number 488

(Reaffirmed 2015)

May 2011

PDF Format
14.

Preconception and Prenatal Carrier Screening for Genetic Diseases in Individuals of Eastern European Jewish Descent

Number 442

(Reaffirmed 2014, Replaces No. 298, August 2004)

October 2009

PDF Format
15.

Preimplantation Genetic Screening for Aneuploidy

Number 430

(Reaffirmed 2014)

March 2009

PDF Format
16.

Screening for Tay - Sachs Disease

Number 318

(Reaffirmed 2014, Replaces No. 162, November 1995)

October 2005

PDF Format
17.

Spinal Muscular Atrophy

Number 432

Reaffirmed 2014

May 2009

PDF Format
18.

The Use of Chromosomal Microarray Analysis in Prenatal Diagnosis

Number 581

(Replaces No. 446, November 2009) (See also Practice Bulletin No. 88)

December 2013

PDF Format
19.

Umbilical Cord Blood Banking

Number 399

(Reaffirmed 2012, Replaces No. 183, April 1997)

February 2008

PDF Format
20.

Update on Carrier Screening for Cystic Fibrosis

Number 486

(Reaffirmed 2014, Replaces No. 325, December 2005)

April 2011

PDF Format

American Congress of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188 | Mailing Address: PO Box 70620, Washington, DC 20024-9998